Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 008809

« Back to Dashboard
NDA 008809 describes M.V.I.-12 (WITHOUT VITAMIN K), which is a drug marketed by Hospira and is included in one NDA. It is available from one supplier. Additional details are available on the M.V.I.-12 (WITHOUT VITAMIN K) profile page.

The generic ingredient in M.V.I.-12 (WITHOUT VITAMIN K) is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e profile page.

Summary for NDA: 008809

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS N' at line 1
Tradename:
2
Applicant:
1
Ingredient:
2
Patents:1